Related Subjects:
|Herpes Varicella-Zoster (Shingles) Infection
|Herpes Viruses
|Herpes Zoster Ophthalmicus (HZO) Shingles
|MonkeyPox
|Mumps
|Measles
|Rubella (German Measles)
|Epstein-Barr Virus infection
|Cytomegalovirus (CMV) infections
|CMV retinitis infections
|Toxoplasmosis
|Respiratory Failure
๐ง Guillain-Barrรฉ Syndrome (GBS): Respiratory function must always be monitored, as failure may occur silently without dyspnoea.
โ ๏ธ Around 20% of patients need mechanical ventilation.
๐ Bedside test = Forced Vital Capacity (FVC); <1.5 L suggests ITU admission.
๐ IVIG within 2 weeks of onset is as effective as plasma exchange (Cochrane review) and more likely to be completed.
๐ฉบ Initial Management of GBS
| Initial Priorities |
- ๐ ABC assessment. ITU if FVC <15โ20 ml/kg or <1 L, abnormal ABG, or hypoxia.
- โก Confirm with nerve conduction studies (e.g., absent F waves).
- ๐ IVIG 0.4 g/kg for 5 days if significant weakness present.
- ๐ก๏ธ VTE prophylaxis, skin care, bowel & bladder management.
- ๐ฅค IV fluids, NG/PEG if swallowing unsafe.
- ๐ซ Regular FVC monitoring to anticipate respiratory decline.
|
๐ About
- Acute onset ascending weakness + areflexia ๐ฝ.
- Potentially life-threatening due to autonomic or respiratory failure.
- Also called Acute Inflammatory Demyelinating Polyneuropathy (AIDP).
๐งฌ Aetiology
- โ๏ธ Autoimmune attack against peripheral nerves (molecular mimicry).
- ๐ฑ Infectious triggers: Campylobacter jejuni, CMV, HIV, HEV, EBV, Mycoplasma, Zika, Lyme.
- Pathology: multifocal demyelination + high CSF protein (albuminocytologic dissociation).
๐ Subtypes of GBS
- AIDP (90%) โ classic form, demyelinating.
- AMAN (5%) โ acute motor axonal neuropathy, often after Campylobacter.
- Miller-Fisher (5%) โ triad: ophthalmoplegia ๐๏ธ, ataxia ๐ถ, areflexia.
- AMSAN (1%) โ motor + sensory axonal neuropathy.
โ ๏ธ Clinical Features
- ๐ผ Ascending weakness (legs โ trunk โ arms โ cranial nerves).
- โ Areflexia.
- ๐ซ Respiratory weakness ยฑ need for ventilation.
- โค๏ธ Dysautonomia: BP swings, arrhythmias, pupillary changes.
- ๐ฉป Back pain, sensory loss, cranial neuropathies.
- ๐ Papilloedema possible due to high CSF protein.
๐งช Investigations
- ๐งซ CSF: Protein โ, normal WCC (may be normal early).
- โก NCS: Slowed conduction, absent F-waves, conduction block.
- ๐ซ ECG: monitor for arrhythmias.
- ๐งฌ Antibody testing rarely useful (anti-GD1a, anti-GQ1b in Miller-Fisher).
๐ฉป Differentials
- Spinal cord lesions (transverse myelitis).
- Myasthenia gravis, botulism.
- Tick paralysis, diphtheria, poliomyelitis.
- Acute porphyria.
๐จ Indications for ITU/Intubation
- FVC <15โ20 ml/kg or <1 L.
- ๐ซ Abnormal inspiratory/expiratory pressures.
- โ Severe bulbar weakness or impaired cough.
- ๐ Autonomic instability or abnormal gases.
๐ Management
- Specific: IVIG (within 2 weeks) or plasma exchange (within 4 weeks). ๐ซ Steroids ineffective.
- Supportive: ITU if required, VTE prophylaxis, physiotherapy, speech therapy, nutrition support.
- Pain: Neuropathic analgesia (gabapentin, carbamazepine). Avoid amitriptyline (arrhythmia risk).
๐ Outcome
- Most improve within 12 months, but recovery may continue up to 5 years.
- 85% recover well; 15% left with disability.
- Poor prognosis: rapid onset, older age, preceding diarrhoea, severe initial weakness.
โ ๏ธ Complications
- Bulbar dysfunction โ aspiration, malnutrition.
- Autonomic storms โ arrhythmias, BP swings.
- Immobility โ pressure sores, DVT/PE, infections.
๐ References
Cases โ GuillainโBarrรฉ Syndrome (GBS)
- Case 1 โ Classic Post-Infectious Ascending Weakness ๐ฆต:
A 32-year-old man develops tingling in his feet one week after a Campylobacter gastroenteritis. Over 3 days, he develops progressive ascending weakness, now unable to climb stairs. Exam: bilateral foot drop, absent ankle reflexes, intact cranial nerves.
Diagnosis: Acute inflammatory demyelinating polyneuropathy (AIDP, most common GBS subtype).
Management: Admit for monitoring; IV immunoglobulin (IVIG) or plasma exchange; monitor vital capacity regularly.
- Case 2 โ MillerโFisher Variant ๐๏ธ:
A 45-year-old woman presents with acute diplopia and unsteady gait. Exam: ophthalmoplegia, ataxia, and areflexia, but normal limb strength. CSF shows albuminocytologic dissociation. Anti-GQ1b antibodies positive.
Diagnosis: MillerโFisher variant of GBS.
Management: IVIG; supportive physiotherapy and rehabilitation.
- Case 3 โ Severe GBS with Respiratory Involvement ๐ซ:
A 28-year-old man presents with progressive ascending weakness, facial diplegia, and dysphagia. Exam: bilateral flaccid paralysis, absent reflexes, reduced single-breath count.
Diagnosis: Severe GBS with bulbar and respiratory muscle involvement.
Management: Admit to ICU; intubation and ventilation if vital capacity falls; IVIG or plasma exchange; multidisciplinary supportive care.
Teaching Commentary ๐ง
GBS is an acute, immune-mediated polyneuropathy triggered by infections (e.g. Campylobacter, EBV, CMV, HIV) or rarely vaccination.
Hallmarks: progressive symmetrical weakness (usually ascending), areflexia, mild sensory symptoms, autonomic instability (arrhythmias, BP swings).
Investigations:
- CSF: albuminocytologic dissociation (โprotein, normal cells).
- Nerve conduction: demyelination (slowed conduction, conduction block).
Complications: respiratory failure (20โ30%), autonomic dysfunction.
Treatment: IVIG or plasma exchange (equally effective); steroids are not helpful. Monitor in hospital until clear plateau or recovery.